Would it be not reasonable for applicants to expect some transparency on the selection process?
I agree that some people would never be pleased - however, a transparent approach might make others in the same boat as me feel better. Hopefully, the below explanation helps and I appreciate it if you cannot address it.
As I mentioned earlier, I have done well on a number of my investments and have close to 35% of my portfolio loaded with RAC which I've been accumulating since entry at 0.3 (average $1) "THANK YOU FOR LIFE-CHANGING RETURNS THUS FAR" - so I don't give a damn about missing out on $15k worth of allocation - which I can buy on market at 8% premium anyhow.
My only issue was that based on my understanding from communications, I felt I was ticking all the boxes, at least under my SMSF account
1. Long term holder
2. Never sold
3. Applied for 30K
4. Transferred money on 3rd day of SPP
So as you can understand, seeing that I missed out to some last-minute applicants isn't what I was looking forward to seeing.
To top it off, seeing full allocation given to internal management made me feel worst as at least in principle management could have decided to scale back on its own allocation - in solidarity with the loyal shareholders.
To be clear, I am still a STRONG believer in RAC and would be buying more as and when appropriate.
In my humble opinion, this is just a minor disagreement I have with one management decision/execution - amongst many many good ones.
- Forums
- ASX - By Stock
- RAC
- Ann: Race raises $29.7 million in oversubscribed SPP
Ann: Race raises $29.7 million in oversubscribed SPP, page-234
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.92 |
Change
-0.020(1.03%) |
Mkt cap ! $331.3M |
Open | High | Low | Value | Volume |
$1.93 | $1.96 | $1.91 | $97.81K | 50.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13146 | $1.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.93 | 1323 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4928 | 1.915 |
2 | 13146 | 1.910 |
1 | 900 | 1.905 |
3 | 3225 | 1.900 |
1 | 1239 | 1.895 |
Price($) | Vol. | No. |
---|---|---|
1.930 | 2800 | 2 |
1.935 | 300 | 1 |
1.940 | 4000 | 1 |
1.945 | 770 | 1 |
1.950 | 2564 | 1 |
Last trade - 10.57am 16/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online